1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol has been researched along with hydroxyindoleacetic acid in 2 studies
Studies (1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol) | Trials (1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol) | Recent Studies (post-2010) (1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol) | Studies (hydroxyindoleacetic acid) | Trials (hydroxyindoleacetic acid) | Recent Studies (post-2010) (hydroxyindoleacetic acid) |
---|---|---|---|---|---|
9 | 4 | 1 | 8,911 | 322 | 594 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banken, L; Dingemanse, J; Guentert, TW; Holford, NH | 1 |
Anttila, M; Heinonen, E; Helminen, A; Huupponen, R; Laine, K; Mäki-Ikola, O; Reinikainen, K; Scheinin, M | 1 |
2 trial(s) available for 1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol and hydroxyindoleacetic acid
Article | Year |
---|---|
Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor.
Topics: Administration, Oral; Adult; Benzamides; Biological Availability; Chromatography, High Pressure Liquid; Humans; Hydroxyindoleacetic Acid; Male; Metabolic Clearance Rate; Moclobemide; Models, Biological; Monoamine Oxidase Inhibitors; Naphthols; Propylene Glycols; Random Allocation | 1994 |
Lack of adverse interactions between concomitantly administered selegiline and citalopram.
Topics: Adult; Antidepressive Agents; Citalopram; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Epinephrine; Humans; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; Naphthols; Norepinephrine; Placebos; Prolactin; Propylene Glycols; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin | 1997 |